<DOC>
	<DOCNO>NCT01863433</DOCNO>
	<brief_summary>This study ass immune ( antibody ) response safety bioCSL split virion , inactivate influenza vaccine contain 2013/2014 formulation Enzira® vaccine healthy adult volunteer age 18 60 year .</brief_summary>
	<brief_title>A Study Assess Immunogenicity Safety Trivalent Influenza Vaccine Containing 2013/2014 Formulation Enzira® Vaccine Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Males female age 18 60 year time vaccination . Females childbearing potential ( i.e. , ovulate , premenopausal , surgically sterile ) must abstinent willing use medically accept contraceptive regimen duration study . Females childbearing potential must return negative urine pregnancy test result prior vaccination vaccine . Known hypersensitivity previous vaccination influenza vaccine allergy egg , ovalbumin , chicken protein , neomycin , polymyxin , component vaccine . Clinical sign active infection . A clinically significant medical condition . Vaccination seasonal experimental influenza virus vaccine 6 month precede study entry . Females pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>